The antipsychotic drug sulpiride does not affect bodyweight in male rats. Is insulin resistance involved?

European Journal of Pharmacology

Volumn 447, Issue 1, 2002, Pages 91-98

  Baptista, Trino ^a,b   Lacruz, Anny ^a   Pàez, Ximena ^a   Hernàndez, Luis ^a   Beaulieu, Serge ^b  

^a Universidad De Los Andes Facultad de Medicina   (Venezuela)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Antipsychotic drugs; Dopamine; Feeding; Glucose; Insulin; Lateral hypothalamus; Leptin; Obesity

Indexed keywords

DOPAMINE; LEPTIN; LIPID; NEUROLEPTIC AGENT; PRASTERONE SULFATE; PROLACTIN; SULPIRIDE; TESTOSTERONE; THYROTROPIN; THYROXINE; 3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE RECEPTOR; GLOBULIN; GONADOTROPIN; HOMOVANILLIC ACID; INSULIN; RISPERIDONE; THYROID HORMONE;

ANIMAL; ARTICLE; BLOOD; BODY WEIGHT; DOSE RESPONSE; DRINKING; DRUG EFFECT; EATING; INSULIN RESISTANCE; LATERAL HYPOTHALAMUS; MALE; METABOLISM; RAT; WISTAR RAT; ANIMAL EXPERIMENT; BLOOD LEVEL; CONTROLLED STUDY; FEEDING; FLUID INTAKE; FOOD INTAKE; GLUCOSE TOLERANCE; HYPERPROLACTINEMIA; HYPOTHALAMUS; INSULIN SENSITIVITY; MICRODIALYSIS; NONHUMAN; OBESITY; PRIORITY JOURNAL; RECEPTOR BLOCKING; SEX DIFFERENCE; STEROID BINDING;

ANIMALS; ANTIPSYCHOTIC AGENTS; BODY WEIGHT; DEHYDROEPIANDROSTERONE SULFATE; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRINKING; EATING; HYPOTHALAMIC AREA, LATERAL; INSULIN RESISTANCE; LEPTIN; LIPIDS; MALE; PROLACTIN; RATS; RATS, WISTAR; SULPIRIDE; TESTOSTERONE; THYROTROPIN; THYROXINE; ANIMAL; SUPPORT, NON-U.S. GOV'T;

EID: 0037188754     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)01816-2     Document Type: Article

References (52)

1. Antipsychotic-induced weight gain: A comprehensive research synthesis
2. Effect of chlorpromazine on insulin release in vivo and in vitro in the rat
3. Body weight gain induced by antipsychotic drugs: Mechanisms and management
4. 2 receptors involved?
5. Puberty modifies sulpiride effects on body weight in rats
6. Systemic sulpiride increases dopamine metabolites in the lateral hypothalamus
7. Long-term administration of clozapine does not modify body weight and feeding in rats
8. Enhancement of amphetamine anorexia after chronic administration of sulpiride in rats
9. Lithium and body weight gain
10. Tamoxifen prevents sulpiride-induced weight gain in female rats
11. Amantadine in the treatment of neuroleptic-induced obesity in rats: Behavioral, endocrine and neurochemical correlates
12. Glucose tolerance and insulin serum levels in an animal model of obesity induced by antipsychotic drugs
13. Mechanism of the neuroleptic-induced obesity in rats
14. Glucose tolerance and serum insulin levels in an animal model of obesity induced by subacute or chronic administration of antipsychotic drugs
15. Endocrine and metabolic profile in the obesity associated to typical antipsychotic drug-administration
16. Glucose-insulin metabolism in chronic schizophrenia
17. Serum leptin levels increase rapidily after initiation of clozapine therapy
18. Insulin binding and action on adipocytes from female rats with experimentally-induced chronic hyperprolactinemia
19. Insulin resistance: An adaptation for weight maintenance
20. Effect of chlorpromazine on blood glucose and plasma insulin in man
21. Peripheral glucose metabolism in human hyperprolactinemia
22. Increased bodyweight associated with prolactin secreting pituitary adenomas: Weight loss with normalization of prolactin levels
23. Prolactin stimulates food intake in a dose-dependent manner
24. Prevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medications
25. Leptin - Much more than a satiety signal
26. Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: A five-year naturalistic study
27. Effects of testosterone on muscle insulin sensitivity and morphology in female rats
28. Obesity and insulin resistance
29. Body weight and leptin plasma levels during treatment with antipsychotic drugs
30. Antipsychotic drug-induced obesity in rats: Correlation between leptin, insulin and body weight during sulpiride treatment
31. Giant prolactinomas: A retrospective review
32. Effect of estrogen on hyperprolactinemia-induced glucose intolerance in SHN mice
33. Different effects of antipsychotic drugs on insulin release in vitro
34. Hyperprolactinemia stimulates food intake in the female rat
35. The effect of neuroleptic drugs on serum level in the male rat
36. Sulpiride injections in the lateral hypothalamus induce feeding and drinking in rats
37. Mechanism of the body weight increase induced by systemic sulpiride
38. Effects of antipsychotic drugs on cytokine networks
39. Preclinical investigation for antipsychotics induced weight gain
40. Human genomics and obesity: Finding appropriate drug targets
41. Blood glucose and prolactin in hyperprolactinemic rats exposed to restraint and surgical stress
42. Receptor pharmacology of neuroleptics: Relation to clinical effects
43. Neuroanatomical specificity of prolactin-induced hyperphagia in virgin female rats
44. Severe hyperprolactinemia is associated with decreased insulin binding in vitro and insulin resistance in vitro
45. Decreased sensitivity to insulin in women with microprolactinomas
46. 2 antagonist sulpiride
47. Atypical antipsychotics and weight gain - A systematic review
48. Sulpiride: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in schizophrenia
49. Bodyweight gain with atypical antipsychotics: A comparative review